Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Glenn A. Weitzman is active.

Publication


Featured researches published by Glenn A. Weitzman.


American Journal of Obstetrics and Gynecology | 1992

The effect of benzo(a)pyrene on murine ovarian and corpora lutea volumes

Michael M. Miller; David R. Plowchalk; Glenn A. Weitzman; Steve N. London; Donald R. Mattison

OBJECTIVE Women who smoke have impaired fertility and experience menopause at an earlier age. This experiment determined the effect of benzo(a)pyrene, a polycyclic aromatic hydrocarbon contained in cigarette smoke, on murine ovarian volume, total corpora lutea volume, individual corpora lutea volumes, and corpora lutea numbers. STUDY DESIGN C57BL/6N mice were treated with intraperitoneal injections of 0 to 500 mg/kg benzo(a)pyrene in corn oil. The 20 mice at each dose were divided into four groups of five each and were killed at 1, 2, 3, or 4 weeks after treatment. Ovaries were serially sectioned and analyzed morphometrically. RESULTS Benzo(a)pyrene produced a dose- and time-dependent decrease in ovarian volume, total corpora lutea volume, and number of corpora lutea per ovary. This effect was transitory at low doses with complete recovery of corpora lutea by 4 weeks. Compensatory hypertrophy of the individual corpora lutea occurred during the recovery phase. Ovarian function did not return in animals treated with the two highest doses. CONCLUSION Benzo(a)pyrene is a murine ovarian toxicant that inhibits corpus luteum formation in a dose- and time-dependent fashion.


Fertility and Sterility | 2001

Male partner screening before in vitro fertilization: preselecting patients who require intracytoplasmic sperm injection with the sperm penetration assay

Melanie R Freeman; Anthony E. Archibong; James J. Mrotek; Christine M. Whitworth; Glenn A. Weitzman; George A. Hill

OBJECTIVES To determine the diagnostic accuracy of the sperm penetration assay (SPA) and standard semen parameters for subsequent fertilization in in vitro fertilization-embryo transfer (IVF-ET). DESIGN Prospective study. SETTING Andrology Laboratory, and university research laboratory. PATIENTS Two hundred sixteen couples undergoing male-partner screening before IVF-ET (265 cycles). INTERVENTION(S) Male-partner screening (semen analyses [SA] and SPA), standard IVF-ET procedures, follow-up of fertilization in IVF-ET. MAIN OUTCOME MEASURE(S) Diagnostic accuracy of SA and SPA for prediction of fertilization in IVF-ET. RESULT(S) The SPA predicted IVF fertilization with high negative (84%) and positive (98%) predictive rates, and correct prediction in 88% of cycles. In contrast, sperm concentration, motility, morphology, and complete SA showed poor diagnostic accuracy, with correct prediction of IVF fertilization in 64%, 65%, 45%, and 68% of cycles, respectively. CONCLUSION(S) Very low sperm concentration and/or motility were good predictors of poor IVF fertilization, however, low to normal semen parameters were not predictive of successful IVF fertilization. The SPA is a useful screening tool that predicts IVF fertilization with high diagnostic accuracy. The SPA may be useful to discriminate between those couples with a high probability of normal fertilization in IVF and those with a low probability of normal fertilization that may benefit from assisted fertilization by intracytoplasmic sperm injection (ICSI).


Reproductive Toxicology | 1992

Morphometric assessment of the murine ovarian toxicity of 7,12-dimethylbenz(a)anthracene

Glenn A. Weitzman; Michael M. Miller; Steve N. London; Donald R. Mattison

7,12-Dimethylbenz(a)anthracene (DMBA) is a polycyclic aromatic hydrocarbon and a component of cigarette smoke that has been identified as a murine reproductive toxicant. The morphometric parameters of total ovarian volume, individual corpus luteum volumes, and total corpora lutea volume were measured in C57BL/6N mice treated with DMBA. Each group received single intraperitoneal injections of 0, 0.1, 1.0, or 10 mg/kg and were sacrificed at 1, 2, 3, or 4 weeks after treatment. DMBA produced a dose-dependent decrease in ovarian volume and number of corpora lutea in each ovary. The observed reduction in total corpora lutea volume did not fully account for the loss in total ovarian volume. This is consistent with previous descriptions of a toxic effect on all ovarian components including growing and resting follicles. Growing follicles that escaped the toxic effects of DMBA and achieved ovulation resulted in a corpus luteum that appeared histologically normal. Morphometric analysis of this animal model further defines the dynamic changes in the mouse ovary in response to DMBA.


Reproductive Toxicology | 1993

Methylene blue but not indigo carmine is toxic to human luteal cells in vitro

Maha M. Mahadevan; Glenn A. Weitzman; Scott Hogan; Stephanie M. Breckinridge; Michael M. Miller

Methylene blue (MB) is reported to be teratogenic when injected intra-amniotically. Indigo carmine (IC) appears to be a safe alternative. To determine if MB has potential detrimental effects on ovarian tissue, we compared the effect of MB and IC on human granulosa luteal cell (GC) function in vitro. Human oocyte-cumulus complexes were obtained during in vitro fertilization cycles and one to three were placed in an organ culture dish. After insemination with sperm, oocytes were removed the day after retrieval and the attached GC were washed daily for 3 more days by changing 2 mL of culture medium. All the dishes were treated with human chorionic gonadotropin (hCG) for the next 24 h and progesterone (P) production during this interval was taken as baseline. Test chemicals were added with hCG for the next 48 h with daily media changes. The P production during the last 24 h of chemical treatment was expressed as a percentage of the baseline. MB significantly reduced P production whereas IC did not appear to have any effect. Moreover, under inverted microscopy more than 90% of the GC cells contained several small bluish intracellular granules when exposed to 0.01% MB but not 0.01% IC. These results indicate that MB may be taken up and processed by GC cells and inhibits P production. This finding adds to previous reports on the use of in vitro GC assay to identify potential reproductive toxicants. The clinical significance of this preliminary study needs further investigation.


Reproductive Biomedicine Online | 2018

A single blastocyst biopsy resulting in a mosaic and euploid profile: a case report

Amy Jones; J.B. Whitney; Ping Zou; Glenn A. Weitzman; Melanie R. Freeman; M.C. Schiewe


Fertility and Sterility | 2013

Antimullerian hormone versus the clomiphene citrate challenge test for evaluation of ovarian reserve prior to in vitro fertilization

Abby C Eblen; Melanie R. Freeman; George A. Hill; Christine M. Whitworth; Glenn A. Weitzman


Fertility and Sterility | 2012

Day 4 embryo biopsy for preimplantation genetic screening

A.E. Jones; J.W. Miller; George A. Hill; Christine M. Whitworth; Glenn A. Weitzman; Abby C Eblen


Fertility and Sterility | 2004

Elective cryopreservation of embryos at the blastocyst stage to prevent OHSS − High success rate and accurate patient management

S.L. McKinney; Glenn A. Weitzman; Melanie R. Freeman; Christine M. Whitworth; Abby C Eblen; George A. Hill


Fertility and Sterility | 2003

A four-year study of clomiphene citrate challenge test results

Jennifer W. Miller; George A. Hill; Christine M. Whitworth; Glenn A. Weitzman; Abby C Eblen; Melanie R. Freeman


Fertility and Sterility | 2003

Anonymous oocyte donation: what is the most efficient use of this limited resource?

Melanie R. Freeman; Kelli S. Millett; Christine M. Whitworth; Glenn A. Weitzman; Abby C Eblen; George A. Hill

Collaboration


Dive into the Glenn A. Weitzman's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

George A. Hill

Vanderbilt University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Melanie R. Freeman

Vanderbilt University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Abby C Eblen

University of Louisville

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge